For years, cellulite treatments have focused on improving the appearance of dimpling through creams, massage and aesthetic procedures. Now, new research is exploring whether the condition could be better understood by looking beneath the skin.
Research led by Italian professor Pasquale Motolese has examined the role of the extracellular matrix — the structural network surrounding cells — in the biological processes associated with cellulite. This research has helped inform the development of Alidya, an injectable treatment designed to target these processes rather than simply addressing the appearance of skin dimpling.
Understanding Cellulite
According to Motolese’s research, several processes may contribute to the development of cellulite.
Changes in microcirculation can affect oxygen delivery and the removal of metabolic by-products. This may contribute to oxidative stress and inflammation in surrounding tissue, while changes in connective tissue can influence how fat compartments interact with the skin.
Together, these processes can contribute to the uneven texture commonly associated with cellulite.
How Alidya Works
Alidya is administered through a series of small injections, using a technique known as mesotherapy.
Its formulation includes chelating agents designed to bind certain metal ions, alongside calcium ascorbate, an antioxidant. The treatment also contains amino acids including methionine, glycine and isoleucine, which are intended to support processes involved in connective-tissue health.
The treatment is designed to work within deeper tissue rather than simply targeting the visible surface appearance.
What Does the Research Show?
Early clinical research has produced promising findings, although the evidence base is still developing.
One recent study involving 24 women assessed a programme of six weekly Alidya treatments. Researchers reported structural changes measured using high-frequency ultrasound, including reductions in subcutaneous tissue thickness and improvements in the appearance of fat protrusions associated with dimpling.
The study also reported changes in thigh circumference and BMI. However, the small sample size means larger and longer-term studies are needed to establish how consistently the treatment works.
Who Might Consider Alidya?
Alidya is primarily marketed for areas such as the thighs and buttocks and is generally aimed at mild to moderate cellulite.
Cellulite is extremely common and is not simply a reflection of body weight or fitness. Its appearance can vary considerably between individuals, and treatments can produce different results.
Anyone considering an injectable aesthetic treatment should consult a qualified medical professional to determine whether it is appropriate for them and discuss potential risks and alternatives.
What Happens During Treatment?
Treatment is typically performed as a series of sessions rather than a single appointment. Clinics commonly recommend several treatments spaced approximately a week apart, although the exact protocol can vary.
The treatment area is cleansed and mapped before the product is administered through small injections or a cannula. Appointments are generally relatively short.
Temporary redness, swelling or bruising can occur following injections.
Is There Downtime?
Alidya is promoted as a treatment with minimal downtime, although patients can experience temporary injection-site reactions.
Clinics may also recommend avoiding certain activities and products for a short period following treatment.
As with any injectable procedure, treatment should only be carried out by an appropriately qualified practitioner using an authorised product.
The bottom line: Alidya represents an emerging approach to cellulite treatment that focuses on the biological processes beneath the skin. While early findings are encouraging, more research is needed before its effectiveness can be considered firmly established.
Main Image: Novuskin Med Spa
